VanEck Pharmaceutical ETF (NASDAQ:PPH – Get Free Report) was the target of a large decrease in short interest in August. As of August 15th, there was short interest totalling 1,670,000 shares, a decrease of 17.3% from the July 31st total of 2,020,000 shares. Based on an average daily volume of 142,100 shares, the days-to-cover ratio is presently 11.8 days.
VanEck Pharmaceutical ETF Price Performance
NASDAQ PPH opened at $99.43 on Friday. VanEck Pharmaceutical ETF has a 1 year low of $74.05 and a 1 year high of $99.44. The stock has a market capitalization of $670.16 million, a PE ratio of 21.04 and a beta of 0.72. The company’s 50 day simple moving average is $93.88 and its two-hundred day simple moving average is $90.90.
VanEck Pharmaceutical ETF Cuts Dividend
The company also recently announced a dividend, which was paid on Friday, July 5th. Shareholders of record on Monday, July 1st were paid a $0.3558 dividend. The ex-dividend date was Monday, July 1st.
Hedge Funds Weigh In On VanEck Pharmaceutical ETF
About VanEck Pharmaceutical ETF
The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.
Featured Stories
- Five stocks we like better than VanEck Pharmaceutical ETF
- What is the Nikkei 225 index?
- Birkenstock’s Sudden Slide—Why It Might Be Your Next Big Win
- NYSE Stocks Give Investors a Variety of Quality Options
- Veeva’s Stock Jumps on Stellar Q2 Results—Don’t Miss Out
- Investing In Automotive Stocks
- MarketBeat Week in Review – 8/26 – 8/30
Receive News & Ratings for VanEck Pharmaceutical ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Pharmaceutical ETF and related companies with MarketBeat.com's FREE daily email newsletter.